Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells.

acute myeloid leukemia apoptosis mitochondria quercetin vascular endothelial growth factor/PI3K/Akt

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 27 02 2020
accepted: 29 10 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 29 12 2020
Statut: epublish

Résumé

Acute myeloid leukemia (AML) is an aggressive haematological malignancy characterized by highly proliferative accumulation of immature and dysfunctional myeloid cells. Quercetin (Qu), one kind of flavonoid, exhibits anti-cancer property in multiple types of solid tumor, but its effect on acute myeloid leukemia is less studied, and the underlying mechanisms still largely unknown. This study aimed to explore the specific target and potential mechanism of quercetin-induced cell death in AML. First, we found that quercetin induces cell death in the form of apoptosis, which was caspase dependent. Second, we found that quercetin-induced apoptosis depends on the decrease of mitochondria membrane potential (MMP) and Bcl-2 proteins. With quantitative chemical proteomics, we observed the downregulation of VEGFR2 and PI3K/Akt signaling in quercetin-treated cells. Consistently, cell studies also identified that VEGFR2 and PI3K/Akt signaling pathways are involved in the action of quercetin on mitochondria and Bcl-2 proteins. The decrease of MMP and cell death could be rescued when PI3K/Akt signaling is activated, suggesting that VEGFR2 and PI3K/Akt exert as upstream regulators for quercetin effect on apoptosis induction in AML cells. In conclusion, our findings from this study provide convincing evidence that quercetin induces cell death via downregulation of VEGF/Akt signaling pathways and mitochondria-mediated apoptosis in AML cells.

Identifiants

pubmed: 33362534
doi: 10.3389/fphar.2020.534171
pii: 534171
pmc: PMC7758733
doi:

Types de publication

Journal Article

Langues

eng

Pagination

534171

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Shi, Li, Chen, Zhang, Wu, Wang, Chen, Dai, Feng, Chatterjee, Li, Huang, Wei, Wang, Lu and Zhou.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Apoptosis. 2017 Feb;22(2):239-253
pubmed: 27888447
Cell Res. 2013 Apr;23(4):508-23
pubmed: 23337583
Gene. 2018 Jul 20;664:50-57
pubmed: 29678660
Br J Cancer. 2007 Oct 8;97(7):877-82
pubmed: 17848952
Arch Physiol Biochem. 2019 Sep 28;:1-9
pubmed: 31564166
Cancer Lett. 2008 Oct 8;269(2):315-25
pubmed: 18467024
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10857-62
pubmed: 11553814
Nat Commun. 2019 Apr 8;10(1):1606
pubmed: 30962435
N Engl J Med. 2015 Sep 17;373(12):1136-52
pubmed: 26376137
Br J Haematol. 2009 Jun;145(6):836-8
pubmed: 19388942
BMC Res Notes. 2012 Sep 20;5:513
pubmed: 22994964
Cold Spring Harb Perspect Biol. 2015 Dec 01;7(12):
pubmed: 26626938
Blood. 2010 Sep 2;116(9):1539-47
pubmed: 20472832
Cancer Prev Res (Phila). 2014 Dec;7(12):1240-50
pubmed: 25293876
Int J Clin Exp Pathol. 2015 May 01;8(5):5282-90
pubmed: 26191229
Arch Toxicol. 2015 Jul;89(7):1103-17
pubmed: 25138434
Life Sci. 2019 Nov 1;236:116933
pubmed: 31614146
J Cell Biochem. 2015 Jun;116(6):1101-12
pubmed: 25536282
ACS Nano. 2019 Nov 26;13(11):12511-12524
pubmed: 31664821
EMBO J. 2012 Mar 7;31(5):1095-108
pubmed: 22343943
Nat Med. 2011 Nov 07;17(11):1359-70
pubmed: 22064426
Bone Marrow Res. 2016;2016:5043483
pubmed: 26998362
Cell Mol Life Sci. 2013 Apr;70(8):1307-17
pubmed: 22833169
Cancer Res. 2018 Feb 1;78(3):731-741
pubmed: 29229602
J Clin Med. 2016 Mar 05;5(3):
pubmed: 26959069
PLoS One. 2012;7(10):e47516
pubmed: 23094058
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Blood. 2016 Jan 7;127(1):53-61
pubmed: 26660429
J Biol Chem. 2007 Aug 17;282(33):24131-45
pubmed: 17580304
Lancet. 2016 Jul 30;388(10043):518-29
pubmed: 26853587
Apoptosis. 2017 Apr;22(4):544-557
pubmed: 28188387
J Nutr Biochem. 2019 Jul;69:108-119
pubmed: 31078904
Nat Rev Cancer. 2002 Sep;2(9):647-56
pubmed: 12209154
Sci Rep. 2018 Feb 22;8(1):3459
pubmed: 29472583
Clin Breast Cancer. 2000 Sep;1 Suppl 1:S80-4
pubmed: 11970755
Stroke. 2007 Jan;38(1):105-10
pubmed: 17158334
Methods Mol Biol. 2018;1709:107-127
pubmed: 29177655
Crit Rev Oncog. 2012;17(1):51-67
pubmed: 22471664
Int J Mol Sci. 2017 Jul 13;18(7):
pubmed: 28703746
Sci Rep. 2016 Feb 26;6:22146
pubmed: 26915414
J Cell Physiol. 2019 Feb;234(2):1913-1924
pubmed: 30105796
Br J Haematol. 1991 Dec;79(4):562-6
pubmed: 1772777

Auteurs

Huan Shi (H)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Department of Physiology, School of Medicine, Hunan University of Medicine, Huaihua, China.

Xin-Yu Li (XY)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Yao Chen (Y)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Xing Zhang (X)

Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Yong Wu (Y)

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.

Zi-Xuan Wang (ZX)

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.

Pan-Hong Chen (PH)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Hui-Qi Dai (HQ)

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.

Ji Feng (J)

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.

Sayantan Chatterjee (S)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Zhong-Jie Li (ZJ)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Xiao-Wei Huang (XW)

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.

Hong-Qiao Wei (HQ)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Jigang Wang (J)

Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Guo-Dong Lu (GD)

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.
Key Laboratory of High-incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education of China, Nanning, China.
Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Jing Zhou (J)

Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Classifications MeSH